ASCO: Combo Hormone Tx Promising in Prostate Cancer
CHICAGO (MedPage Today) -- A combination attack on androgens in metastatic prostate cancer resistant to initial hormone therapy drove down testosterone levels and appeared safe, according to a proof of concept study.
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Primary Care | Prostate Cancer | Study